Shield To Acquire Echodyne In Transaction Valued at $5.3 Bln; Raises 2.5 Bln At $28.8 Bln Valuation

By Reuters News

- Blackstone Inc. BX.N:

  • SHIELD TO ACQUIRE ECHODYNE IN A TRANSACTION VALUED AT $5.3 BILLION AND RAISE $2.5 BILLION AT A $28.8 BILLION VALUATION

  • SHIELD: RAISING $2.5 BILLION TO SUPPORT TRANSACTION, INCLUDING $1 BILLION IN SERIES H FUNDING

  • SHIELD: $2.5 BILLION RAISE INCLUDES A $1 BILLION STRUCTURED EQUITY INVESTMENT FROM FUNDS MANAGED BY BLACKSTONE

  • SHIELD: $2.5 BILLION RAISE INCLUDES $500 MILLION IN DEBT FINANCING LED BY JPMORGAN CHASE BANK, N.A. AS SOLE ARRANGER

  • SHIELD : SERIES H FUNDING CO-LED BY DISRUPTIVE AND INNOVATION X CAPITAL

  • SHIELD: OF $5.3 BILLION TRANSACTION VALUE, UP TO AN ADDITIONAL $500 MILLION IS CONTINGENT ON ECHODYNE MEETING AGREED PERFORMANCE TARGETS

Further company coverage: BX.N

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk